Simulations Plus (Simulations Plus) Risk Assessment

View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Simulations Plus is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Simulations Plus's Risk Assessment

For the Health Information Services subindustry, Simulations Plus's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Simulations Plus's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Risk Assessment falls into.

Simulations Plus (NAS:SLP) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Simulations Plus Risk Assessment Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Simulations Plus (Simulations Plus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

42505 Tenth Street West, Lancaster, CA, USA, 93534-7059

Website

https://www.simulations-plus.com

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.

Executives

John Kenneth Paglia	director	746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz	director, 10 percent owner, officer: Chairman and CEO	42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii	officer: Division President	42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange	director	42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang	officer: President, Immunetrics	42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor	officer: Chief Executive Officer	42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly	officer: President, Cognigen Division	42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell	officer: President, DILIsym Division	42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick	officer: CFO	C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner	director	800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans	director	42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen	officer: VP of Human Resources	42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph	director	42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel	officer: CFO	42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr	director, officer: President	1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221